ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1103

Needs Assessment of Musculoskeletal Ultrasound Training in North American Pediatric Rheumatology Fellowship Programs

Megan Perron1, Sonja Ziniel2, Megan Curran3, Jessica Bloom4, Patricia Vega-Fernandez5, Heather Benham6, Karina Torralba7, Deirdre De Ranieri8 and Clara Lin9, 1Children's Hospital Colorado, Division of Rheumatology, Aurora, CO, 2University of Colorado School of Medicine, Department of Pediatrics, Aurora, CO, 3University of Colorado, Aurora, CO, 4University of Colorado, Denver, CO, 5Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Scottish RIte Hospital, North Richland Hills, TX, 7Loma Linda University Faculty Medical Group, Redlands, CA, 8Lurie Children's Hospital, Chicago, IL, 9Children's Hospital Colorado, Aurora, CO

Meeting: ACR Convergence 2022

Keywords: education, medical, Juvenile idiopathic arthritis, Pediatric rheumatology, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Abstracts: Professional Education

Session Type: Abstract Session

Session Time: 10:30AM-11:30AM

Background/Purpose: Musculoskeletal Ultrasound (MSUS) has become widely used in rheumatology practice for diagnosis of arthritis and procedural guidance. A 2017 survey of adult rheumatology fellowship programs in the United States (US) reports that 94% provide MSUS training. In contrast, a 2014 survey of US pediatric rheumatology fellows shows that only 20% receive formal MSUS training. MSUS is advantageous in pediatrics as it does not require radiation or sedation. This study aims to assess interest in, access to, and barriers to MSUS training in pediatric rheumatology fellowship programs in North America.

Methods: A survey was developed by pediatric rheumatology providers with experience in medical and/or MSUS education and refined through 7 cognitive interviews. The questions focused on fellows’ interest in, access/barriers to MSUS training, and program support. Eligible participants included current and recently graduated (< 1 year) pediatric rheumatology fellows at a North American program. REDCap was used to distribute the anonymous survey electronically in March 2022. Descriptive statistics and bivariate analyses using Design-Based Pearson Chi-Squared tests to account for clustering of fellows by institution were performed. Nonresponse bias analyses indicated a low likelihood for bias.

Results: Overall response rate was 78% (88/113) (Table 1). Sixty-eight percent of respondents reported some form of MSUS training, and 86% reported interest in learning MSUS during fellowship. Similarly, 84% of respondents felt MSUS would be beneficial to their career, citing improved confidence in diagnosis of arthritis and clinical skills (85%) as well as improved accuracy with joint injections (82%) as potential benefits (Figure 1). Fourteen percent did not see benefit in MSUS for their career, with the greatest perceived barrier being lack of time (50%). Of those with MSUS training, 23% reported adult-only MSUS education. Only 36% of respondents indicated their program had a formal MSUS curriculum. Two-thirds (63%) of respondents felt that MSUS training should be formally included as part of the pediatric rheumatology fellowship curriculum. Major barriers to MSUS training during fellowship included lack of MSUS-trained faculty (48%), lack of time (45%), and lack of hands-on MSUS sessions (41%) (Figure 2). Those who had access to MSUS training were significantly more interested in MSUS than those without (p=0.004).

Conclusion: This study demonstrates that North American pediatric rheumatology fellows have a strong interest in learning MSUS, but they face significant limitations in accessing MSUS training. Perceived barriers include lack of MSUS-trained faculty, time and access to hands-on training. Fellows and recent graduates with MSUS training during fellowship had greater interest in MSUS compared to those without. This suggests MSUS exposure during fellowship plays a key role in garnering interest and filling the need for more MSUS-trained faculty. MSUS training is of value to pediatric rheumatology fellows and should be incorporated into fellowship curriculum, however, implementation remains a challenge.

Supporting image 1

Table 1. Response Rate and Demographics

Supporting image 2

Figure 1. Perceived Benefits of MSUS to a Career in Pediatric Rheumatology Among Current and Graduated Fellows (n=74)

Supporting image 3

Figure 2. Perceived Barriers to MSUS Training During Fellowship Among Current and Graduated Fellows (n=87)


Disclosures: M. Perron, None; S. Ziniel, None; M. Curran, Novartis; J. Bloom, None; P. Vega-Fernandez, None; H. Benham, None; K. Torralba, None; D. De Ranieri, None; C. Lin, None.

To cite this abstract in AMA style:

Perron M, Ziniel S, Curran M, Bloom J, Vega-Fernandez P, Benham H, Torralba K, De Ranieri D, Lin C. Needs Assessment of Musculoskeletal Ultrasound Training in North American Pediatric Rheumatology Fellowship Programs [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/needs-assessment-of-musculoskeletal-ultrasound-training-in-north-american-pediatric-rheumatology-fellowship-programs/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/needs-assessment-of-musculoskeletal-ultrasound-training-in-north-american-pediatric-rheumatology-fellowship-programs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology